NCT01844661View on ClinicalTrials.gov

Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2016

Conditions

ChildrenSolid TumorsMetastases

Interventions

BIOLOGICAL

CELYVIR

Trial Locations (1)

28009

Hospital Universitario Niño Jesús, Madrid

All Listed Sponsors

collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

OTHER

NCT01844661 - Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. | Biotech Hunter | Biotech Hunter